| UniProt ID | FA76B_HUMAN | |
|---|---|---|
| UniProt AC | Q5HYJ3 | |
| Protein Name | Protein FAM76B | |
| Gene Name | FAM76B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 339 | |
| Subcellular Localization | Nucleus speckle . | |
| Protein Description | ||
| Protein Sequence | MAASALYACTKCTQRYPFEELSQGQQLCKECRIAHPIVKCTYCRSEFQQESKTNTICKKCAQNVKQFGTPKPCQYCNIIAAFIGTKCQRCTNSEKKYGPPQTCEQCKQQCAFDRKEEGRRKVDGKLLCWLCTLSYKRVLQKTKEQRKSLGSSHSNSSSSSLTEKDQHHPKHHHHHHHHHHRHSSSHHKISNLSPEEEQGLWKQSHKSSATIQNETPKKKPKLESKPSNGDSSSINQSADSGGTDNFVLISQLKEEVMSLKRLLQQRDQTILEKDKKLTELKADFQYQESNLRTKMNSMEKAHKETVEQLQAKNRELLKQVAALSKGKKFDKSGSILTSP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAASALYAC ------CHHHHHHHH | 15.32 | 22223895 | |
| 4 | Phosphorylation | ----MAASALYACTK ----CHHHHHHHHCC | 14.85 | 26552605 | |
| 7 | Phosphorylation | -MAASALYACTKCTQ -CHHHHHHHHCCCCC | 10.19 | 25159151 | |
| 10 | Phosphorylation | ASALYACTKCTQRYP HHHHHHHCCCCCCCC | 22.45 | 26552605 | |
| 22 | Phosphorylation | RYPFEELSQGQQLCK CCCHHHHHHHHHHHH | 35.23 | 17525332 | |
| 42 | Phosphorylation | HPIVKCTYCRSEFQQ CHHHHCCCCCHHHHH | 8.71 | - | |
| 45 | Phosphorylation | VKCTYCRSEFQQESK HHCCCCCHHHHHHHC | 38.92 | - | |
| 51 | Phosphorylation | RSEFQQESKTNTICK CHHHHHHHCCCHHHH | 40.20 | - | |
| 52 | Sumoylation | SEFQQESKTNTICKK HHHHHHHCCCHHHHH | 45.07 | - | |
| 52 | Sumoylation | SEFQQESKTNTICKK HHHHHHHCCCHHHHH | 45.07 | - | |
| 69 | Phosphorylation | QNVKQFGTPKPCQYC HHHHHHCCCCCCCHH | 29.45 | 22617229 | |
| 75 | Phosphorylation | GTPKPCQYCNIIAAF CCCCCCCHHHHHHHH | 8.32 | - | |
| 147 | Sumoylation | QKTKEQRKSLGSSHS HHHHHHHHHHCCCCC | 50.13 | - | |
| 147 | Sumoylation | QKTKEQRKSLGSSHS HHHHHHHHHHCCCCC | 50.13 | - | |
| 148 | Phosphorylation | KTKEQRKSLGSSHSN HHHHHHHHHCCCCCC | 39.90 | 25159151 | |
| 151 | Phosphorylation | EQRKSLGSSHSNSSS HHHHHHCCCCCCCCC | 30.12 | 28450419 | |
| 152 | Phosphorylation | QRKSLGSSHSNSSSS HHHHHCCCCCCCCCC | 29.18 | 25159151 | |
| 154 | Phosphorylation | KSLGSSHSNSSSSSL HHHCCCCCCCCCCCC | 40.11 | 28450419 | |
| 156 | Phosphorylation | LGSSHSNSSSSSLTE HCCCCCCCCCCCCCH | 34.31 | 28450419 | |
| 157 | Phosphorylation | GSSHSNSSSSSLTEK CCCCCCCCCCCCCHH | 38.19 | 28450419 | |
| 158 | Phosphorylation | SSHSNSSSSSLTEKD CCCCCCCCCCCCHHH | 24.62 | 28450419 | |
| 159 | Phosphorylation | SHSNSSSSSLTEKDQ CCCCCCCCCCCHHHC | 31.17 | 28450419 | |
| 160 | Phosphorylation | HSNSSSSSLTEKDQH CCCCCCCCCCHHHCC | 41.06 | 28450419 | |
| 162 | Phosphorylation | NSSSSSLTEKDQHHP CCCCCCCCHHHCCCC | 42.83 | 28450419 | |
| 190 | Phosphorylation | SSSHHKISNLSPEEE CCCCCCCCCCCHHHH | 36.20 | 30266825 | |
| 193 | Phosphorylation | HHKISNLSPEEEQGL CCCCCCCCHHHHHCH | 34.22 | 19664994 | |
| 204 | Phosphorylation | EQGLWKQSHKSSATI HHCHHHHCHHHCCCC | 29.20 | 28122231 | |
| 207 | Phosphorylation | LWKQSHKSSATIQNE HHHHCHHHCCCCCCC | 21.56 | 28111955 | |
| 208 | Phosphorylation | WKQSHKSSATIQNET HHHCHHHCCCCCCCC | 33.95 | 28111955 | |
| 210 | Phosphorylation | QSHKSSATIQNETPK HCHHHCCCCCCCCCC | 25.66 | 29396449 | |
| 215 | Phosphorylation | SATIQNETPKKKPKL CCCCCCCCCCCCCCC | 48.21 | 23401153 | |
| 224 | Phosphorylation | KKKPKLESKPSNGDS CCCCCCCCCCCCCCC | 61.37 | 28450419 | |
| 225 | Ubiquitination | KKPKLESKPSNGDSS CCCCCCCCCCCCCCC | 42.99 | 17203973 | |
| 227 | Phosphorylation | PKLESKPSNGDSSSI CCCCCCCCCCCCCCH | 58.12 | 25159151 | |
| 231 | Phosphorylation | SKPSNGDSSSINQSA CCCCCCCCCCHHCCC | 27.64 | 25159151 | |
| 232 | Phosphorylation | KPSNGDSSSINQSAD CCCCCCCCCHHCCCC | 39.72 | 28450419 | |
| 233 | Phosphorylation | PSNGDSSSINQSADS CCCCCCCCHHCCCCC | 29.52 | 30108239 | |
| 237 | Phosphorylation | DSSSINQSADSGGTD CCCCHHCCCCCCCCC | 29.56 | 28450419 | |
| 240 | Phosphorylation | SINQSADSGGTDNFV CHHCCCCCCCCCCEE | 38.55 | 26074081 | |
| 243 | Phosphorylation | QSADSGGTDNFVLIS CCCCCCCCCCEEEHH | 31.15 | 26074081 | |
| 250 | Phosphorylation | TDNFVLISQLKEEVM CCCEEEHHHHHHHHH | 25.87 | 24719451 | |
| 269 | Phosphorylation | LLQQRDQTILEKDKK HHHHHHHHHHHHHHH | 31.64 | - | |
| 325 | Acetylation | KQVAALSKGKKFDKS HHHHHHHCCCCCCCC | 75.50 | 25953088 | |
| 332 | Phosphorylation | KGKKFDKSGSILTSP CCCCCCCCCCCCCCC | 39.35 | 24719451 | |
| 337 | Phosphorylation | DKSGSILTSP----- CCCCCCCCCC----- | 36.96 | 29396449 | |
| 338 | Phosphorylation | KSGSILTSP------ CCCCCCCCC------ | 25.76 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FA76B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FA76B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FA76B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ANM5_HUMAN | PRMT5 | physical | 23455924 | |
| KR107_HUMAN | KRTAP10-7 | physical | 25416956 | |
| KR109_HUMAN | KRTAP10-9 | physical | 25416956 | |
| KR101_HUMAN | KRTAP10-1 | physical | 25416956 | |
| KR10B_HUMAN | KRTAP10-11 | physical | 25416956 | |
| KR108_HUMAN | KRTAP10-8 | physical | 25416956 | |
| KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
| SORL_HUMAN | SORL1 | physical | 26186194 | |
| AEDO_HUMAN | ADO | physical | 26186194 | |
| SORL_HUMAN | SORL1 | physical | 28514442 | |
| AEDO_HUMAN | ADO | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-193, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-193, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND MASSSPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "The proteomic reactor facilitates the analysis of affinity-purifiedproteins by mass spectrometry: application for identifyingubiquitinated proteins in human cells."; Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,Haines D.S., Figeys D.; J. Proteome Res. 6:298-305(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-225 (ISOFORM 2), AND MASSSPECTROMETRY. | |